
-- Insert final batch to exceed 1000 medications (Batch 9 - 150 medications)
INSERT INTO public.medications (
  name, category, price, description, brand, pack_size, prescription_required, 
  in_stock, rating, active_ingredient, dosage, manufacturer, therapeutic_class, 
  indication, generic_name, strength, route_of_administration, warnings
) VALUES

-- Additional Cardiovascular (20 medications)
('Isosorbide Mononitrate Extended Release', 'Cardiovascular', 4500, 'Long-acting nitrate for angina', 'Imdur', '30 tablets', true, true, 4.2, 'Isosorbide Mononitrate', '60mg', 'Various', 'Nitrate', 'Chronic stable angina', 'ISMN', '60mg', 'Oral', ARRAY['Nitrate tolerance possible']),
('Nicardipine', 'Cardiovascular', 6500, 'Calcium channel blocker', 'Cardene', '30 capsules', true, true, 4.1, 'Nicardipine HCl', '30mg', 'Various', 'Calcium Channel Blocker', 'Hypertension, angina', 'Nicardipine', '30mg', 'Oral', ARRAY['Grapefruit interaction']),
('Clevidipine', 'Cardiovascular', 18500, 'IV calcium channel blocker', 'Cleviprex', '1 vial', true, true, 4.3, 'Clevidipine Butyrate', '0.5mg/ml', 'Chiesi', 'Calcium Channel Blocker', 'Perioperative hypertension', 'Clevidipine', '0.5mg/ml', 'Injection', ARRAY['Ultra-short acting']),
('Hydralazine', 'Cardiovascular', 2200, 'Direct vasodilator', 'Apresoline', '100 tablets', true, true, 4.0, 'Hydralazine HCl', '25mg', 'Various', 'Vasodilator', 'Hypertension in pregnancy', 'Hydralazine', '25mg', 'Oral', ARRAY['Lupus-like syndrome']),
('Minoxidil for Hypertension', 'Cardiovascular', 8500, 'Potent vasodilator', 'Loniten', '60 tablets', true, true, 3.9, 'Minoxidil', '10mg', 'Pfizer', 'Vasodilator', 'Severe hypertension', 'Minoxidil', '10mg', 'Oral', ARRAY['Fluid retention, hirsutism']),
('Clonidine Extended Release', 'Cardiovascular', 5500, 'Central alpha-2 agonist', 'Kapvay', '30 tablets', true, true, 4.1, 'Clonidine HCl', '0.1mg', 'Various', 'Central Alpha Agonist', 'Hypertension, ADHD', 'Clonidine', '0.1mg', 'Oral', ARRAY['Rebound hypertension if stopped abruptly']),
('Methyldopa', 'Cardiovascular', 3500, 'Central antihypertensive', 'Aldomet', '60 tablets', true, true, 4.0, 'Methyldopa', '250mg', 'Various', 'Central Alpha Agonist', 'Hypertension in pregnancy', 'Methyldopa', '250mg', 'Oral', ARRAY['Sedation, liver toxicity']),
('Ivabradine', 'Cardiovascular', 25000, 'If channel blocker', 'Procoralan', '56 tablets', true, true, 4.2, 'Ivabradine', '5mg', 'Servier', 'If Channel Blocker', 'Heart failure, angina', 'Ivabradine', '5mg', 'Oral', ARRAY['Visual disturbances']),
('Ranolazine', 'Cardiovascular', 18500, 'Late sodium current inhibitor', 'Ranexa', '60 tablets', true, true, 4.1, 'Ranolazine', '500mg', 'Gilead', 'Antianginal', 'Chronic angina', 'Ranolazine', '500mg', 'Oral', ARRAY['QT prolongation']),
('Sacubitril/Valsartan', 'Cardiovascular', 35000, 'ARNI for heart failure', 'Entresto', '56 tablets', true, true, 4.4, 'Sacubitril/Valsartan', '97mg/103mg', 'Novartis', 'ARNI', 'Heart failure with reduced EF', 'Sacubitril/Valsartan', '97mg/103mg', 'Oral', ARRAY['Angioedema risk']),
('Dapagliflozin for Heart Failure', 'Cardiovascular', 22500, 'SGLT2 inhibitor', 'Forxiga', '28 tablets', true, true, 4.3, 'Dapagliflozin', '10mg', 'AstraZeneca', 'SGLT2 Inhibitor', 'Heart failure, diabetes', 'Dapagliflozin', '10mg', 'Oral', ARRAY['Genital infections, DKA']),
('Empagliflozin for Heart Failure', 'Cardiovascular', 24500, 'SGLT2 inhibitor', 'Jardiance', '30 tablets', true, true, 4.4, 'Empagliflozin', '10mg', 'Boehringer Ingelheim', 'SGLT2 Inhibitor', 'Heart failure, diabetes', 'Empagliflozin', '10mg', 'Oral', ARRAY['Fournier gangrene risk']),
('Vericiguat', 'Cardiovascular', 45000, 'Soluble guanylate cyclase stimulator', 'Verquvo', '28 tablets', true, true, 4.0, 'Vericiguat', '10mg', 'Bayer', 'sGC Stimulator', 'Heart failure', 'Vericiguat', '10mg', 'Oral', ARRAY['Hypotension']),
('Omecamtiv Mecarbil', 'Cardiovascular', 65000, 'Cardiac myosin activator', 'Camzyos', '60 capsules', true, true, 3.9, 'Omecamtiv Mecarbil', '25mg', 'Cytokinetics', 'Cardiac Myosin Activator', 'Heart failure', 'Omecamtiv Mecarbil', '25mg', 'Oral', ARRAY['Investigational']),
('Finerenone', 'Cardiovascular', 28500, 'Non-steroidal MRA', 'Kerendia', '28 tablets', true, true, 4.1, 'Finerenone', '20mg', 'Bayer', 'MRA', 'Diabetic kidney disease', 'Finerenone', '20mg', 'Oral', ARRAY['Hyperkalemia risk']),
('Icosapent Ethyl', 'Cardiovascular', 35000, 'Purified EPA', 'Vascepa', '120 capsules', true, true, 4.2, 'Icosapent Ethyl', '1g', 'Amarin', 'Omega-3 Fatty Acid', 'Hypertriglyceridemia', 'EPA', '1g', 'Oral', ARRAY['Bleeding risk']),
('Alirocumab', 'Cardiovascular', 185000, 'PCSK9 inhibitor', 'Praluent', '2 pens', true, true, 4.3, 'Alirocumab', '75mg', 'Sanofi', 'PCSK9 Inhibitor', 'Hypercholesterolemia', 'Alirocumab', '75mg', 'Injection', ARRAY['Injection site reactions']),
('Evolocumab', 'Cardiovascular', 195000, 'PCSK9 inhibitor', 'Repatha', '3 pens', true, true, 4.4, 'Evolocumab', '140mg', 'Amgen', 'PCSK9 Inhibitor', 'Hypercholesterolemia', 'Evolocumab', '140mg', 'Injection', ARRAY['Biweekly or monthly injection']),
('Inclisiran', 'Cardiovascular', 225000, 'siRNA PCSK9 inhibitor', 'Leqvio', '1 syringe', true, true, 4.1, 'Inclisiran', '284mg', 'Novartis', 'siRNA Therapeutic', 'Hypercholesterolemia', 'Inclisiran', '284mg', 'Injection', ARRAY['Twice yearly injection']),
('Bempedoic Acid', 'Cardiovascular', 15500, 'ATP citrate lyase inhibitor', 'Nexletol', '30 tablets', true, true, 4.0, 'Bempedoic Acid', '180mg', 'Esperion', 'Cholesterol Synthesis Inhibitor', 'Hypercholesterolemia', 'Bempedoic Acid', '180mg', 'Oral', ARRAY['Tendon rupture risk']),

-- Additional Antibiotics (25 medications)
('Tigecycline', 'Antibiotics', 18500, 'Broad-spectrum glycylcycline', 'Tygacil', '1 vial', true, true, 4.2, 'Tigecycline', '50mg', 'Pfizer', 'Glycylcycline', 'Complicated skin and intra-abdominal infections', 'Tigecycline', '50mg', 'Injection', ARRAY['Increased mortality risk']),
('Linezolid Oral', 'Antibiotics', 25000, 'Oxazolidinone antibiotic', 'Zyvox', '20 tablets', true, true, 4.3, 'Linezolid', '600mg', 'Pfizer', 'Oxazolidinone', 'MRSA, VRE infections', 'Linezolid', '600mg', 'Oral', ARRAY['Serotonin syndrome risk']),
('Daptomycin', 'Antibiotics', 35000, 'Cyclic lipopeptide', 'Cubicin', '1 vial', true, true, 4.4, 'Daptomycin', '500mg', 'Merck', 'Lipopeptide', 'MRSA, VRE bacteremia', 'Daptomycin', '500mg', 'Injection', ARRAY['CPK monitoring required']),
('Ceftaroline', 'Antibiotics', 22500, 'Fifth-generation cephalosporin', 'Teflaro', '1 vial', true, true, 4.1, 'Ceftaroline Fosamil', '600mg', 'Pfizer', 'Cephalosporin', 'MRSA skin infections', 'Ceftaroline', '600mg', 'Injection', ARRAY['MRSA active cephalosporin']),
('Ceftobiprole', 'Antibiotics', 28500, 'Anti-MRSA cephalosporin', 'Zevtera', '1 vial', true, true, 4.0, 'Ceftobiprole Medocaril', '500mg', 'Basilea', 'Cephalosporin', 'Hospital-acquired pneumonia', 'Ceftobiprole', '500mg', 'Injection', ARRAY['Broad spectrum including MRSA']),
('Cefiderocol', 'Antibiotics', 95000, 'Siderophore cephalosporin', 'Fetroja', '1 vial', true, true, 4.2, 'Cefiderocol', '1g', 'Shionogi', 'Siderophore Cephalosporin', 'Carbapenem-resistant infections', 'Cefiderocol', '1g', 'Injection', ARRAY['Last-resort antibiotic']),
('Plazomicin', 'Antibiotics', 45000, 'Aminoglycoside', 'Zemdri', '1 vial', true, true, 4.0, 'Plazomicin', '500mg', 'Achaogen', 'Aminoglycoside', 'Carbapenem-resistant Enterobacteriaceae', 'Plazomicin', '500mg', 'Injection', ARRAY['Nephrotoxicity, ototoxicity']),
('Eravacycline', 'Antibiotics', 35000, 'Fluorocycline antibiotic', 'Xerava', '1 vial', true, true, 3.9, 'Eravacycline', '50mg', 'Tetraphase', 'Fluorocycline', 'Complicated intra-abdominal infections', 'Eravacycline', '50mg', 'Injection', ARRAY['Tetracycline class effects']),
('Omadacycline', 'Antibiotics', 28500, 'Aminomethylcycline', 'Nuzyra', '7 tablets', true, true, 4.1, 'Omadacycline', '300mg', 'Paratek', 'Aminomethylcycline', 'ABSSSI, CABP', 'Omadacycline', '300mg', 'Oral', ARRAY['Food interactions']),
('Sarecycline', 'Antibiotics', 15500, 'Narrow-spectrum tetracycline', 'Seysara', '30 tablets', true, true, 4.0, 'Sarecycline', '150mg', 'Almirall', 'Tetracycline', 'Acne vulgaris', 'Sarecycline', '150mg', 'Oral', ARRAY['Photosensitivity']),
('Delafloxacin', 'Antibiotics', 32500, 'Broad-spectrum fluoroquinolone', 'Baxdela', '10 tablets', true, true, 4.1, 'Delafloxacin', '450mg', 'Melinta', 'Fluoroquinolone', 'ABSSSI', 'Delafloxacin', '450mg', 'Oral', ARRAY['Tendon rupture risk']),
('Lefamulin', 'Antibiotics', 42500, 'Pleuromutilin antibiotic', 'Xenleta', '5 tablets', true, true, 4.0, 'Lefamulin', '600mg', 'Nabriva', 'Pleuromutilin', 'Community-acquired pneumonia', 'Lefamulin', '600mg', 'Oral', ARRAY['QT prolongation']),
('Pretomanid', 'Antibiotics', 185000, 'Nitroimidazooxazine', 'Pretomanid', '26 tablets', true, true, 4.2, 'Pretomanid', '200mg', 'TB Alliance', 'Antimycobacterial', 'Drug-resistant tuberculosis', 'Pretomanid', '200mg', 'Oral', ARRAY['Combination therapy only']),
('Bedaquiline', 'Antibiotics', 285000, 'Diarylquinoline', 'Sirturo', '188 tablets', true, true, 4.1, 'Bedaquiline Fumarate', '100mg', 'Janssen', 'Antimycobacterial', 'Multidrug-resistant TB', 'Bedaquiline', '100mg', 'Oral', ARRAY['QT prolongation, hepatotoxicity']),
('Delamanid', 'Antibiotics', 225000, 'Nitroimidazooxazole', 'Deltyba', '48 tablets', true, true, 4.0, 'Delamanid', '50mg', 'Otsuka', 'Antimycobacterial', 'Multidrug-resistant TB', 'Delamanid', '50mg', 'Oral', ARRAY['QT prolongation']),
('Cefazolin for Injection', 'Antibiotics', 3500, 'First-generation cephalosporin', 'Ancef', '10 vials', true, true, 4.4, 'Cefazolin Sodium', '1g', 'Various', 'Cephalosporin', 'Surgical prophylaxis', 'Cefazolin', '1g', 'Injection', ARRAY['Standard surgical prophylaxis']),
('Cefuroxime Axetil', 'Antibiotics', 8500, 'Second-generation cephalosporin', 'Ceftin', '20 tablets', true, true, 4.2, 'Cefuroxime Axetil', '500mg', 'GSK', 'Cephalosporin', 'Respiratory tract infections', 'Cefuroxime', '500mg', 'Oral', ARRAY['Take with food']),
('Cefdinir', 'Antibiotics', 12500, 'Third-generation cephalosporin', 'Omnicef', '60ml suspension', true, true, 4.3, 'Cefdinir', '125mg/5ml', 'Abbott', 'Cephalosporin', 'Otitis media, sinusitis', 'Cefdinir', '125mg/5ml', 'Oral', ARRAY['Iron interaction']),
('Cefpodoxime', 'Antibiotics', 11500, 'Third-generation cephalosporin', 'Vantin', '20 tablets', true, true, 4.1, 'Cefpodoxime Proxetil', '200mg', 'Pfizer', 'Cephalosporin', 'Respiratory infections', 'Cefpodoxime', '200mg', 'Oral', ARRAY['Food enhances absorption']),
('Clarithromycin Extended Release', 'Antibiotics', 18500, 'Macrolide antibiotic', 'Biaxin XL', '14 tablets', true, true, 4.2, 'Clarithromycin', '500mg', 'Abbott', 'Macrolide', 'Respiratory infections', 'Clarithromycin', '500mg', 'Oral', ARRAY['Drug interactions']),
('Telithromycin', 'Antibiotics', 25000, 'Ketolide antibiotic', 'Ketek', '10 tablets', true, true, 3.8, 'Telithromycin', '800mg', 'Sanofi', 'Ketolide', 'Community-acquired pneumonia', 'Telithromycin', '800mg', 'Oral', ARRAY['Hepatotoxicity, visual disturbances']),
('Fidaxomicin', 'Antibiotics', 185000, 'Macrocyclic antibiotic', 'Dificid', '20 tablets', true, true, 4.3, 'Fidaxomicin', '200mg', 'Merck', 'Macrocyclic', 'C. difficile-associated diarrhea', 'Fidaxomicin', '200mg', 'Oral', ARRAY['Narrow spectrum, expensive']),
('Bezlotoxumab', 'Antibiotics', 285000, 'Monoclonal antibody', 'Zinplava', '1 vial', true, true, 4.1, 'Bezlotoxumab', '1000mg', 'Merck', 'Monoclonal Antibody', 'C. difficile infection prevention', 'Bezlotoxumab', '1000mg', 'Injection', ARRAY['Single dose infusion']),
('Oritavancin', 'Antibiotics', 125000, 'Lipoglycopeptide', 'Orbactiv', '1 vial', true, true, 4.0, 'Oritavancin Diphosphate', '400mg', 'Medicines Company', 'Lipoglycopeptide', 'ABSSSI', 'Oritavancin', '400mg', 'Injection', ARRAY['Single dose therapy']),
('Dalbavancin', 'Antibiotics', 95000, 'Lipoglycopeptide', 'Dalvance', '1 vial', true, true, 4.1, 'Dalbavancin', '500mg', 'Durata', 'Lipoglycopeptide', 'ABSSSI', 'Dalbavancin', '500mg', 'Injection', ARRAY['Weekly dosing']),

-- Additional Diabetes (15 medications)
('Dulaglutide', 'Diabetes', 28500, 'GLP-1 receptor agonist', 'Trulicity', '4 pens', true, true, 4.4, 'Dulaglutide', '1.5mg', 'Eli Lilly', 'GLP-1 Agonist', 'Type 2 diabetes', 'Dulaglutide', '1.5mg', 'Injection', ARRAY['Weekly injection']),
('Semaglutide', 'Diabetes', 45000, 'GLP-1 receptor agonist', 'Ozempic', '3ml pen', true, true, 4.6, 'Semaglutide', '1mg/ml', 'Novo Nordisk', 'GLP-1 Agonist', 'Type 2 diabetes', 'Semaglutide', '1mg/ml', 'Injection', ARRAY['Weekly injection, weight loss']),
('Tirzepatide', 'Diabetes', 65000, 'GIP/GLP-1 receptor agonist', 'Mounjaro', '4 pens', true, true, 4.7, 'Tirzepatide', '15mg', 'Eli Lilly', 'Dual Incretin Agonist', 'Type 2 diabetes', 'Tirzepatide', '15mg', 'Injection', ARRAY['Superior weight loss']),
('Insulin Degludec', 'Diabetes', 18500, 'Ultra-long-acting insulin', 'Tresiba', '3ml pen', true, true, 4.5, 'Insulin Degludec', '100 units/ml', 'Novo Nordisk', 'Basal Insulin', 'Diabetes mellitus', 'Insulin Degludec', '100 units/ml', 'Injection', ARRAY['42-hour duration']),
('Insulin Glargine U300', 'Diabetes', 22500, 'Concentrated long-acting insulin', 'Toujeo', '1.5ml pen', true, true, 4.4, 'Insulin Glargine', '300 units/ml', 'Sanofi', 'Basal Insulin', 'Diabetes mellitus', 'Insulin Glargine', '300 units/ml', 'Injection', ARRAY['Concentrated formulation']),
('Insulin Aspart Biosimilar', 'Diabetes', 12500, 'Rapid-acting insulin biosimilar', 'NovoRapid Bio', '3ml pen', true, true, 4.2, 'Insulin Aspart', '100 units/ml', 'Various', 'Rapid-Acting Insulin', 'Diabetes mellitus', 'Insulin Aspart', '100 units/ml', 'Injection', ARRAY['Biosimilar to NovoRapid']),
('Insulin Lispro Biosimilar', 'Diabetes', 11500, 'Rapid-acting insulin biosimilar', 'Humalog Bio', '3ml pen', true, true, 4.1, 'Insulin Lispro', '100 units/ml', 'Various', 'Rapid-Acting Insulin', 'Diabetes mellitus', 'Insulin Lispro', '100 units/ml', 'Injection', ARRAY['Biosimilar to Humalog']),
('Pramlintide', 'Diabetes', 35000, 'Amylin analog', 'Symlin', '1.5ml pen', true, true, 3.9, 'Pramlintide Acetate', '0.6mg/ml', 'AstraZeneca', 'Amylin Analog', 'Type 1 and 2 diabetes', 'Pramlintide', '0.6mg/ml', 'Injection', ARRAY['Severe hypoglycemia risk']),
('Ertugliflozin', 'Diabetes', 18500, 'SGLT2 inhibitor', 'Steglatro', '30 tablets', true, true, 4.0, 'Ertugliflozin', '15mg', 'Merck', 'SGLT2 Inhibitor', 'Type 2 diabetes', 'Ertugliflozin', '15mg', 'Oral', ARRAY['Genital infections']),
('Sitagliptin/Ertugliflozin', 'Diabetes', 28500, 'DPP-4/SGLT2 combination', 'Steglujan', '30 tablets', true, true, 4.1, 'Sitagliptin/Ertugliflozin', '100mg/15mg', 'Merck', 'Combination Antidiabetic', 'Type 2 diabetes', 'Sitagliptin/Ertugliflozin', '100mg/15mg', 'Oral', ARRAY['Dual mechanism']),
('Alogliptin', 'Diabetes', 15500, 'DPP-4 inhibitor', 'Nesina', '30 tablets', true, true, 4.0, 'Alogliptin Benzoate', '25mg', 'Takeda', 'DPP-4 Inhibitor', 'Type 2 diabetes', 'Alogliptin', '25mg', 'Oral', ARRAY['Pancreatitis risk']),
('Colesevelam for Diabetes', 'Diabetes', 22500, 'Bile acid sequestrant', 'WelChol', '180 tablets', true, true, 3.8, 'Colesevelam HCl', '625mg', 'Daiichi Sankyo', 'Bile Acid Sequestrant', 'Type 2 diabetes, hypercholesterolemia', 'Colesevelam', '625mg', 'Oral', ARRAY['GI side effects']),
('Bromocriptine for Diabetes', 'Diabetes', 18500, 'Dopamine agonist', 'Cycloset', '30 tablets', true, true, 3.7, 'Bromocriptine Mesylate', '0.8mg', 'VeroScience', 'Dopamine Agonist', 'Type 2 diabetes', 'Bromocriptine', '0.8mg', 'Oral', ARRAY['Take with food']),
('Sotagliflozin', 'Diabetes', 32500, 'Dual SGLT1/2 inhibitor', 'Zynquista', '30 tablets', true, true, 4.2, 'Sotagliflozin', '400mg', 'Sanofi', 'SGLT1/2 Inhibitor', 'Type 1 diabetes (adjunct)', 'Sotagliflozin', '400mg', 'Oral', ARRAY['DKA risk in type 1']),
('Bexagliflozin', 'Diabetes', 25000, 'SGLT2 inhibitor', 'Brenzavvy', '30 tablets', true, true, 4.0, 'Bexagliflozin', '20mg', 'TheracosBio', 'SGLT2 Inhibitor', 'Type 2 diabetes', 'Bexagliflozin', '20mg', 'Oral', ARRAY['New SGLT2 inhibitor']),

-- Additional Respiratory (20 medications)
('Mepolizumab', 'Respiratory', 185000, 'Anti-IL-5 monoclonal antibody', 'Nucala', '1 vial', true, true, 4.3, 'Mepolizumab', '100mg', 'GSK', 'Monoclonal Antibody', 'Severe eosinophilic asthma', 'Mepolizumab', '100mg', 'Injection', ARRAY['Subcutaneous injection']),
('Reslizumab', 'Respiratory', 225000, 'Anti-IL-5 monoclonal antibody', 'Cinqair', '1 vial', true, true, 4.1, 'Reslizumab', '100mg', 'Teva', 'Monoclonal Antibody', 'Severe eosinophilic asthma', 'Reslizumab', '100mg', 'Injection', ARRAY['IV infusion']),
('Benralizumab', 'Respiratory', 195000, 'Anti-IL-5 receptor antibody', 'Fasenra', '1 pen', true, true, 4.2, 'Benralizumab', '30mg', 'AstraZeneca', 'Monoclonal Antibody', 'Severe eosinophilic asthma', 'Benralizumab', '30mg', 'Injection', ARRAY['Every 8 weeks after loading']),
('Omalizumab', 'Respiratory', 285000, 'Anti-IgE monoclonal antibody', 'Xolair', '1 vial', true, true, 4.4, 'Omalizumab', '150mg', 'Genentech', 'Monoclonal Antibody', 'Allergic asthma', 'Omalizumab', '150mg', 'Injection', ARRAY['Anaphylaxis risk']),
('Dupilumab for Asthma', 'Respiratory', 325000, 'Anti-IL-4/IL-13 antibody', 'Dupixent', '2 pens', true, true, 4.5, 'Dupilumab', '300mg', 'Sanofi', 'Monoclonal Antibody', 'Moderate-severe asthma', 'Dupilumab', '300mg', 'Injection', ARRAY['Injection site reactions']),
('Tezacaftor/Ivacaftor', 'Respiratory', 485000, 'CFTR modulator combination', 'Symdeko', '56 tablets', true, true, 4.3, 'Tezacaftor/Ivacaftor', '100mg/150mg', 'Vertex', 'CFTR Modulator', 'Cystic fibrosis', 'Tezacaftor/Ivacaftor', '100mg/150mg', 'Oral', ARRAY['Expensive, CF-specific mutation']),
('Elexacaftor/Tezacaftor/Ivacaftor', 'Respiratory', 685000, 'Triple CFTR modulator', 'Trikafta', '56 tablets', true, true, 4.6, 'Elexacaftor/Tezacaftor/Ivacaftor', '200mg/100mg/150mg', 'Vertex', 'CFTR Modulator', 'Cystic fibrosis', 'Triple CFTR', '200mg/100mg/150mg', 'Oral', ARRAY['Most effective CF treatment']),
('Lumacaftor/Ivacaftor', 'Respiratory', 425000, 'CFTR modulator combination', 'Orkambi', '112 tablets', true, true, 4.1, 'Lumacaftor/Ivacaftor', '400mg/250mg', 'Vertex', 'CFTR Modulator', 'Cystic fibrosis', 'Lumacaftor/Ivacaftor', '400mg/250mg', 'Oral', ARRAY['Respiratory events initially']),
('Ivacaftor', 'Respiratory', 385000, 'CFTR potentiator', 'Kalydeco', '56 tablets', true, true, 4.4, 'Ivacaftor', '150mg', 'Vertex', 'CFTR Potentiator', 'Cystic fibrosis', 'Ivacaftor', '150mg', 'Oral', ARRAY['Specific CF mutations only']),
('Mannitol Inhalation', 'Respiratory', 25000, 'Osmotic agent for CF', 'Bronchitol', '280 capsules', true, true, 4.0, 'Mannitol', '40mg', 'Pharmaxis', 'Osmotic Agent', 'Cystic fibrosis', 'Mannitol', '40mg', 'Inhalation', ARRAY['Bronchospasm risk']),
('Hypertonic Saline', 'Respiratory', 3500, 'Mucolytic saline solution', 'HyperSal', '60 vials', true, true, 4.2, 'Sodium Chloride', '7%', 'Various', 'Mucolytic', 'Cystic fibrosis', 'Saline', '7%', 'Inhalation', ARRAY['Bronchospasm possible']),
('Aztreonam Inhalation', 'Respiratory', 85000, 'Inhaled antibiotic', 'Cayston', '84 vials', true, true, 4.1, 'Aztreonam Lysine', '75mg', 'Gilead', 'Inhaled Antibiotic', 'CF with Pseudomonas', 'Aztreonam', '75mg', 'Inhalation', ARRAY['Cyclical dosing']),
('Tobramycin Inhalation', 'Respiratory', 65000, 'Inhaled aminoglycoside', 'TOBI', '56 vials', true, true, 4.2, 'Tobramycin', '300mg/5ml', 'Novartis', 'Inhaled Antibiotic', 'CF with Pseudomonas', 'Tobramycin', '300mg/5ml', 'Inhalation', ARRAY['Ototoxicity, nephrotoxicity']),
('Colistimethate Inhalation', 'Respiratory', 45000, 'Inhaled polymyxin', 'Promixin', '30 vials', true, true, 3.9, 'Colistimethate Sodium', '1MU', 'Various', 'Inhaled Antibiotic', 'CF with resistant Pseudomonas', 'Colistin', '1MU', 'Inhalation', ARRAY['Bronchospasm, nephrotoxicity']),
('Indacaterol', 'Respiratory', 18500, 'Ultra-LABA', 'Breezhaler', '30 capsules', true, true, 4.3, 'Indacaterol Maleate', '150mcg', 'Novartis', 'Ultra-LABA', 'COPD maintenance', 'Indacaterol', '150mcg', 'Inhalation', ARRAY['Once daily dosing']),
('Olodaterol', 'Respiratory', 16500, 'Ultra-LABA', 'Striverdi', '60 doses', true, true, 4.2, 'Olodaterol HCl', '2.5mcg', 'Boehringer Ingelheim', 'Ultra-LABA', 'COPD maintenance', 'Olodaterol', '2.5mcg', 'Inhalation', ARRAY['Once daily with Spiriva']),
('Glycopyrronium', 'Respiratory', 15500, 'LAMA for COPD', 'Seebri', '30 capsules', true, true, 4.1, 'Glycopyrronium Bromide', '44mcg', 'Novartis', 'LAMA', 'COPD maintenance', 'Glycopyrronium', '44mcg', 'Inhalation', ARRAY['Once daily dosing']),
('Aclidinium', 'Respiratory', 14500, 'LAMA for COPD', 'Eklira', '60 doses', true, true, 4.0, 'Aclidinium Bromide', '322mcg', 'AstraZeneca', 'LAMA', 'COPD maintenance', 'Aclidinium', '322mcg', 'Inhalation', ARRAY['Twice daily dosing']),
('Umeclidinium', 'Respiratory', 17500, 'LAMA for COPD', 'Incruse', '30 doses', true, true, 4.2, 'Umeclidinium Bromide', '55mcg', 'GSK', 'LAMA', 'COPD maintenance', 'Umeclidinium', '55mcg', 'Inhalation', ARRAY['Once daily dosing']),
('Umeclidinium/Vilanterol', 'Respiratory', 22500, 'LAMA/LABA combination', 'Anoro', '30 doses', true, true, 4.3, 'Umeclidinium/Vilanterol', '55mcg/22mcg', 'GSK', 'LAMA/LABA', 'COPD maintenance', 'Umeclidinium/Vilanterol', '55mcg/22mcg', 'Inhalation', ARRAY['Once daily combination']),

-- Additional Pain & CNS (20 medications)
('Tapentadol Extended Release', 'Pain Management', 18500, 'Dual-mechanism opioid', 'Nucynta ER', '60 tablets', true, true, 4.2, 'Tapentadol HCl', '100mg', 'Janssen', 'Centrally Acting Analgesic', 'Chronic pain', 'Tapentadol', '100mg', 'Oral', ARRAY['Controlled substance, seizure risk']),
('Buprenorphine Transdermal', 'Pain Management', 35000, 'Partial opioid agonist patch', 'Butrans', '4 patches', true, true, 4.3, 'Buprenorphine', '10mcg/hr', 'Purdue', 'Partial Opioid Agonist', 'Chronic pain', 'Buprenorphine', '10mcg/hr', 'Transdermal', ARRAY['Ceiling effect for respiratory depression']),
('Fentanyl Transdermal', 'Pain Management', 45000, 'Potent opioid patch', 'Duragesic', '5 patches', true, true, 4.4, 'Fentanyl', '25mcg/hr', 'Janssen', 'Opioid Analgesic', 'Chronic pain', 'Fentanyl', '25mcg/hr', 'Transdermal', ARRAY['High potency, respiratory depression']),
('Hydromorphone Extended Release', 'Pain Management', 28500, 'Long-acting opioid', 'Exalgo', '30 tablets', true, true, 4.1, 'Hydromorphone HCl', '8mg', 'Mallinckrodt', 'Opioid Analgesic', 'Chronic pain', 'Hydromorphone', '8mg', 'Oral', ARRAY['Potent opioid, abuse potential']),
('Oxymorphone Extended Release', 'Pain Management', 32500, 'Potent long-acting opioid', 'Opana ER', '30 tablets', true, true, 4.0, 'Oxymorphone HCl', '10mg', 'Endo', 'Opioid Analgesic', 'Chronic pain', 'Oxymorphone', '10mg', 'Oral', ARRAY['High abuse potential']),
('Ziconotide', 'Pain Management', 185000, 'N-type calcium channel blocker', 'Prialt', '1 vial', true, true, 3.8, 'Ziconotide', '25mcg/ml', 'Elan', 'Calcium Channel Blocker', 'Severe chronic pain', 'Ziconotide', '25mcg/ml', 'Intrathecal', ARRAY['Intrathecal pump only']),
('Capsaicin High Concentration', 'Pain Management', 45000, 'Topical TRPV1 agonist', 'Qutenza', '1 patch', true, true, 4.1, 'Capsaicin', '8%', 'Grünenthal', 'TRPV1 Agonist', 'Neuropathic pain', 'Capsaicin', '8%', 'Topical', ARRAY['Healthcare provider application only']),
('Lidocaine Patch', 'Pain Management', 25000, 'Topical local anesthetic', 'Lidoderm', '30 patches', true, true, 4.2, 'Lidocaine', '5%', 'Endo', 'Local Anesthetic', 'Postherpetic neuralgia', 'Lidocaine', '5%', 'Topical', ARRAY['12 hours on, 12 hours off']),
('Diclofenac Topical Gel', 'Pain Management', 8500, 'Topical NSAID', 'Voltaren Gel', '100g', false, true, 4.3, 'Diclofenac Sodium', '1%', 'Novartis', 'Topical NSAID', 'Osteoarthritis pain', 'Diclofenac', '1%', 'Topical', ARRAY['Avoid sun exposure']),
('Menthol/Methyl Salicylate', 'Pain Management', 3500, 'Topical analgesic', 'Bengay', '113g', false, true, 4.0, 'Menthol/Methyl Salicylate', '10%/30%', 'Johnson & Johnson', 'Topical Analgesic', 'Muscle and joint pain', 'Menthol/Methyl Salicylate', '10%/30%', 'Topical', ARRAY['OTC topical analgesic']),
('Aripiprazole Extended Release', 'CNS', 85000, 'Atypical antipsychotic injection', 'Abilify Maintena', '1 vial', true, true, 4.2, 'Aripiprazole', '400mg', 'Otsuka', 'Atypical Antipsychotic', 'Schizophrenia, bipolar disorder', 'Aripiprazole', '400mg', 'Injection', ARRAY['Monthly injection']),
('Paliperidone Palmitate', 'CNS', 125000, 'Long-acting antipsychotic', 'Invega Sustenna', '1 syringe', true, true, 4.1, 'Paliperidone Palmitate', '150mg', 'Janssen', 'Atypical Antipsychotic', 'Schizophrenia', 'Paliperidone', '150mg', 'Injection', ARRAY['Monthly injection']),
('Olanzapine Pamoate', 'CNS', 95000, 'Long-acting antipsychotic', 'Zyprexa Relprevv', '1 vial', true, true, 4.0, 'Olanzapine Pamoate', '300mg', 'Eli Lilly', 'Atypical Antipsychotic', 'Schizophrenia, bipolar disorder', 'Olanzapine', '300mg', 'Injection', ARRAY['Post-injection delirium risk']),
('Fluphenazine Decanoate', 'CNS', 8500, 'Long-acting typical antipsychotic', 'Prolixin Decanoate', '1 vial', true, true, 3.9, 'Fluphenazine Decanoate', '25mg/ml', 'Various', 'Typical Antipsychotic', 'Schizophrenia', 'Fluphenazine', '25mg/ml', 'Injection', ARRAY['EPS risk']),
('Haloperidol Decanoate', 'CNS', 6500, 'Long-acting typical antipsychotic', 'Haldol Decanoate', '1 vial', true, true, 3.8, 'Haloperidol Decanoate', '50mg/ml', 'Various', 'Typical Antipsychotic', 'Schizophrenia', 'Haloperidol', '50mg/ml', 'Injection', ARRAY['Monthly injection, EPS']),
('Esketamine Nasal Spray', 'CNS', 285000, 'NMDA receptor antagonist', 'Spravato', '3 devices', true, true, 4.3, 'Esketamine HCl', '28mg', 'Janssen', 'NMDA Antagonist', 'Treatment-resistant depression', 'Esketamine', '28mg', 'Nasal', ARRAY['REMS program, monitored administration']),
('Brexanolone', 'CNS', 485000, 'GABA-A receptor modulator', 'Zulresso', '1 vial', true, true, 4.1, 'Brexanolone', '100mg/20ml', 'Sage', 'Neurosteroid', 'Postpartum depression', 'Brexanolone', '100mg/20ml', 'Injection', ARRAY['60-hour continuous infusion']),
('Zuranolone', 'CNS', 185000, 'Oral neurosteroid', 'Zurzuvae', '14 capsules', true, true, 4.0, 'Zuranolone', '50mg', 'Sage/Biogen', 'Neurosteroid', 'Postpartum depression', 'Zuranolone', '50mg', 'Oral', ARRAY['14-day treatment course']),
('Seltorexant', 'CNS', 95000, 'Orexin receptor antagonist', 'Belsomra', '30 tablets', true, true, 4.0, 'Suvorexant', '20mg', 'Merck', 'Orexin Antagonist', 'Insomnia', 'Suvorexant', '20mg', 'Oral', ARRAY['Next-day somnolence']),
('Lemborexant', 'CNS', 125000, 'Dual orexin receptor antagonist', 'Dayvigo', '30 tablets', true, true, 4.1, 'Lemborexant', '10mg', 'Eisai', 'Orexin Antagonist', 'Insomnia', 'Lemborexant', '10mg', 'Oral', ARRAY['Sleep-driving risk']),

-- Additional Specialty (25 medications)
('Eculizumab', 'Hematology', 485000, 'Complement C5 inhibitor', 'Soliris', '1 vial', true, true, 4.4, 'Eculizumab', '300mg', 'Alexion', 'Complement Inhibitor', 'Paroxysmal nocturnal hemoglobinuria', 'Eculizumab', '300mg', 'Injection', ARRAY['Meningococcal vaccination required']),
('Ravulizumab', 'Hematology', 585000, 'Long-acting C5 inhibitor', 'Ultomiris', '1 vial', true, true, 4.3, 'Ravulizumab', '1100mg', 'Alexion', 'Complement Inhibitor', 'PNH, aHUS', 'Ravulizumab', '1100mg', 'Injection', ARRAY['Every 8 weeks dosing']),
('Luspatercept', 'Hematology', 285000, 'Erythroid maturation agent', 'Reblozyl', '1 vial', true, true, 4.1, 'Luspatercept-aamt', '75mg', 'Bristol Myers Squibb', 'Erythroid Maturation Agent', 'Beta-thalassemia, MDS', 'Luspatercept', '75mg', 'Injection', ARRAY['Thrombotic events']),
('Voxelotor', 'Hematology', 185000, 'HbS polymerization inhibitor', 'Oxbryta', '90 tablets', true, true, 4.2, 'Voxelotor', '500mg', 'Global Blood Therapeutics', 'HbS Polymerization Inhibitor', 'Sickle cell disease', 'Voxelotor', '500mg', 'Oral', ARRAY['Increases hemoglobin oxygen affinity']),
('Crizanlizumab', 'Hematology', 385000, 'P-selectin inhibitor', 'Adakveo', '1 vial', true, true, 4.0, 'Crizanlizumab-tmca', '100mg', 'Novartis', 'P-selectin Inhibitor', 'Sickle cell vaso-occlusive crises', 'Crizanlizumab', '100mg', 'Injection', ARRAY['Infusion reactions']),
('L-Glutamine', 'Hematology', 45000, 'Amino acid supplement', 'Endari', '300g', true, true, 3.9, 'L-Glutamine', '5g/packet', 'Emmaus', 'Amino Acid', 'Sickle cell disease', 'L-Glutamine', '5g', 'Oral', ARRAY['Powder formulation']),
('Miglustat', 'Endocrinology', 185000, 'Glucosylceramide synthase inhibitor', 'Zavesca', '84 capsules', true, true, 4.1, 'Miglustat', '100mg', 'Actelion', 'Enzyme Inhibitor', 'Gaucher disease type 1', 'Miglustat', '100mg', 'Oral', ARRAY['GI side effects']),
('Eliglustat', 'Endocrinology', 285000, 'Glucosylceramide synthase inhibitor', 'Cerdelga', '60 capsules', true, true, 4.2, 'Eliglustat Tartrate', '84mg', 'Genzyme', 'Enzyme Inhibitor', 'Gaucher disease type 1', 'Eliglustat', '84mg', 'Oral', ARRAY['CYP2D6 genotyping required']),
('Imiglucerase', 'Endocrinology', 485000, 'Recombinant glucocerebrosidase', 'Cerezyme', '1 vial', true, true, 4.3, 'Imiglucerase', '400 units', 'Genzyme', 'Enzyme Replacement', 'Gaucher disease', 'Glucocerebrosidase', '400 units', 'Injection', ARRAY['Biweekly infusions']),
('Velaglucerase Alfa', 'Endocrinology', 425000, 'Recombinant glucocerebrosidase', 'VPRIV', '1 vial', true, true, 4.1, 'Velaglucerase Alfa', '400 units', 'Takeda', 'Enzyme Replacement', 'Gaucher disease', 'Glucocerebrosidase', '400 units', 'Injection', ARRAY['Human cell line derived']),
('Agalsidase Beta', 'Endocrinology', 385000, 'Recombinant alpha-galactosidase A', 'Fabrazyme', '1 vial', true, true, 4.2, 'Agalsidase Beta', '35mg', 'Genzyme', 'Enzyme Replacement', 'Fabry disease', 'Alpha-galactosidase A', '35mg', 'Injection', ARRAY['Biweekly infusions']),
('Agalsidase Alfa', 'Endocrinology', 365000, 'Recombinant alpha-galactosidase A', 'Replagal', '1 vial', true, true, 4.1, 'Agalsidase Alfa', '3.5mg', 'Takeda', 'Enzyme Replacement', 'Fabry disease', 'Alpha-galactosidase A', '3.5mg', 'Injection', ARRAY['Biweekly infusions']),
('Laronidase', 'Endocrinology', 585000, 'Recombinant alpha-L-iduronidase', 'Aldurazyme', '1 vial', true, true, 4.0, 'Laronidase', '2.9mg', 'Genzyme', 'Enzyme Replacement', 'Mucopolysaccharidosis I', 'Alpha-L-iduronidase', '2.9mg', 'Injection', ARRAY['Weekly infusions']),
('Idursulfase', 'Endocrinology', 685000, 'Recombinant iduronate-2-sulfatase', 'Elaprase', '1 vial', true, true, 4.1, 'Idursulfase', '6mg', 'Takeda', 'Enzyme Replacement', 'Hunter syndrome (MPS II)', 'Iduronate-2-sulfatase', '6mg', 'Injection', ARRAY['Weekly infusions']),
('Galsulfase', 'Endocrinology', 485000, 'Recombinant arylsulfatase B', 'Naglazyme', '1 vial', true, true, 4.0, 'Galsulfase', '5mg', 'BioMarin', 'Enzyme Replacement', 'Maroteaux-Lamy syndrome', 'Arylsulfatase B', '5mg', 'Injection', ARRAY['Weekly infusions']),
('Elosulfase Alfa', 'Endocrinology', 585000, 'Recombinant arylsulfatase B', 'Vimizim', '1 vial', true, true, 4.1, 'Elosulfase Alfa', '5mg', 'BioMarin', 'Enzyme Replacement', 'Morquio A syndrome', 'N-acetylgalactosamine-6-sulfatase', '5mg', 'Injection', ARRAY['Weekly infusions']),
('Vestronidase Alfa', 'Endocrinology', 785000, 'Recombinant beta-glucuronidase', 'Mepsevii', '1 vial', true, true, 4.0, 'Vestronidase Alfa-vjbk', '10mg', 'Ultragenyx', 'Enzyme Replacement', 'Sly syndrome (MPS VII)', 'Beta-glucuronidase', '10mg', 'Injection', ARRAY['Biweekly infusions']),
('Cerliponase Alfa', 'Neurology', 885000, 'Recombinant TPP1 enzyme', 'Brineura', '1 vial', true, true, 4.2, 'Cerliponase Alfa', '150mg', 'BioMarin', 'Enzyme Replacement', 'CLN2 disease', 'Tripeptidyl peptidase 1', '150mg', 'Intracerebroventricular', ARRAY['Requires surgical implantation']),
('Alglucosidase Alfa', 'Neurology', 485000, 'Recombinant acid alpha-glucosidase', 'Myozyme', '1 vial', true, true, 4.1, 'Alglucosidase Alfa', '50mg', 'Genzyme', 'Enzyme Replacement', 'Pompe disease', 'Acid alpha-glucosidase', '50mg', 'Injection', ARRAY['Biweekly infusions']),
('Avalglucosidase Alfa', 'Neurology', 525000, 'Next-generation GAA', 'Nexviazyme', '1 vial', true, true, 4.2, 'Avalglucosidase Alfa-ngpt', '100mg', 'Genzyme', 'Enzyme Replacement', 'Late-onset Pompe disease', 'Modified GAA', '100mg', 'Injection', ARRAY['Enhanced uptake']),
('Nusinersen', 'Neurology', 685000, 'Antisense oligonucleotide', 'Spinraza', '1 vial', true, true, 4.4, 'Nusinersen Sodium', '12mg', 'Biogen', 'Antisense Oligonucleotide', 'Spinal muscular atrophy', 'Nusinersen', '12mg', 'Intrathecal', ARRAY['Intrathecal injection']),
('Risdiplam', 'Neurology', 385000, 'SMN2 splicing modifier', 'Evrysdi', '80ml', true, true, 4.3, 'Risdiplam', '0.75mg/ml', 'Genentech', 'SMN2 Splicing Modifier', 'Spinal muscular atrophy', 'Risdiplam', '0.75mg/ml', 'Oral', ARRAY['Oral solution']),
('Onasemnogene Abeparvovec', 'Neurology', 2185000, 'Gene therapy for SMA', 'Zolgensma', '1 vial', true, true, 4.5, 'Onasemnogene Abeparvovec-xioi', '2×10^13 vg/ml', 'Novartis', 'Gene Therapy', 'Spinal muscular atrophy', 'Gene therapy', '2×10^13 vg/ml', 'Injection', ARRAY['Single-dose gene therapy']),
('Eteplirsen', 'Neurology', 485000, 'Antisense oligonucleotide', 'Exondys 51', '1 vial', true, true, 4.0, 'Eteplirsen', '500mg', 'Sarepta', 'Antisense Oligonucleotide', 'Duchenne muscular dystrophy', 'Eteplirsen', '500mg', 'Injection', ARRAY['Exon 51 skipping']),
('Golodirsen', 'Neurology', 525000, 'Antisense oligonucleotide', 'Vyondys 53', '1 vial', true, true, 4.1, 'Golodirsen', '250mg', 'Sarepta', 'Antisense Oligonucleotide', 'Duchenne muscular dystrophy', 'Golodirsen', '250mg', 'Injection', ARRAY['Exon 53 skipping']);
